Suppr超能文献

大剂量单次服用维生素D可作为2019冠状病毒病的预防和治疗手段。

A Single Large Dose of Vitamin D Could be Used as a Means of Coronavirus Disease 2019 Prevention and Treatment.

作者信息

Liu Guoqiang, Hong Tianpei, Yang Jin

机构信息

Department of Endocrinology and Metabolism, Peking University Third Hospital, Beijing 100191, People's Republic of China.

出版信息

Drug Des Devel Ther. 2020 Aug 21;14:3429-3434. doi: 10.2147/DDDT.S271754. eCollection 2020.

Abstract

There is no specific and effective medication for coronavirus disease 2019 (COVID-19), and avaccine is not available in recent months. Here, we hypothesize that a single large dose of vitamin D (Vit D) could be an option for trial in COVID-19. Vit D deficiency or insufficiency is very common in the general population as well as in patients with COVID-19. It has been shown that low Vit D level is associated with viral infection, and Vit D supplementation is beneficial for people infected with viruses, such as HIV and hepatitis C virus. Although COVID-19 is a respiratory disease, the morbidity and mortality of this disease are driven by coagulopathy. Clinical studies have shown that Vit D can exert anticoagulant effects. Vit D, a lipid-soluble vitamin, can be administered as a draught. Vit D supplementation is safe and has rare toxic events. In addition, the cost of Vit D is fairly low. Based on these observations, we speculate that a single dose of 300,000 IU Vit D may have a role in the prevention and treatment of COVID-19.

摘要

对于2019冠状病毒病(COVID-19),目前尚无特效药物,且近几个月内也没有可用疫苗。在此,我们推测大剂量单次服用维生素D(Vit D)可能是一种可用于COVID-19试验的选择。维生素D缺乏或不足在普通人群以及COVID-19患者中都非常常见。研究表明,低维生素D水平与病毒感染有关,补充维生素D对感染病毒(如艾滋病毒和丙型肝炎病毒)的人有益。尽管COVID-19是一种呼吸道疾病,但该疾病的发病率和死亡率是由凝血病驱动的。临床研究表明,维生素D可发挥抗凝作用。维生素D作为一种脂溶性维生素,可以制成药剂服用。补充维生素D是安全的,且很少发生毒性事件。此外,维生素D的成本相当低。基于这些观察结果,我们推测单次服用300,000国际单位维生素D可能在COVID-19的预防和治疗中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6622/7457388/d6392c34baba/DDDT-14-3429-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验